Product
AGN-242428
1 clinical trial
1 indication
Indication
Dry Eye SyndromeClinical trial
A Multicenter, Vehicle-controlled, Double-Masked, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of AGN-242428 and AGN-231868 in Participants With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2022-03-18